MedTrace Logo

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

NCT01863368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2015-08-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare Systane® ULTRA lubricant eye drops to OPTIVE® lubricating eye drops for ocular surface staining within dry eye subjects and to evaluate the safety of Systane® ULTRA after 3 months of use.

Conditions

  • Dry Eye Syndrome

Interventions

OTHER

Preservative-free saline solution eyedrops

1 drop in each eye, 4 times a day, for up to two weeks as washout prior to Phase I and Phase II.

OTHER

Systane® ULTRA lubricant eyedrops

OTHER

OPTIVE® lubricating eyedrops

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Steve Burmaster · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01863368 on ClinicalTrials.gov